FATE
Fate Therapeutics·NASDAQ
--
--(--)
--
--(--)
2.71 / 10
Underperform
Technical rating is Underperform with a 2.71/10 score. Recent data shows bearish MACD death cross and persistent long upper and lower shadows, yielding no bullish signals. The chart suggests weak momentum and heightened downside risk.
Analysis Checks(0/3)
Long Upper Shadow
Score3.5/10
Win Rate50.65%
Hist. Signals77
Avg Return0.80%
Score3.5/10
Win Rate50.65%
Hist. Signals77
Avg Return0.80%
MACD Death Cross
Score1/10
Win Rate27.27%
Hist. Signals11
Avg Return0.21%
Score1/10
Win Rate27.27%
Hist. Signals11
Avg Return0.21%
Long Lower Shadow
Score3.63/10
Win Rate47.92%
Hist. Signals48
Avg Return1.88%
Score3.63/10
Win Rate47.92%
Hist. Signals48
Avg Return1.88%
Long Upper Shadow
Score3.5/10
Win Rate50.65%
Hist. Signals77
Avg Return0.80%
Score3.5/10
Win Rate50.65%
Hist. Signals77
Avg Return0.80%
Long Lower Shadow
Score3.63/10
Win Rate47.92%
Hist. Signals48
Avg Return1.88%
Score3.63/10
Win Rate47.92%
Hist. Signals48
Avg Return1.88%
MACD Death Cross
Score1/10
Win Rate27.27%
Hist. Signals11
Avg Return0.21%
Score1/10
Win Rate27.27%
Hist. Signals11
Avg Return0.21%
What is the current technical signals for FATE?
- FATE presents a Underperform setup with a Technical Score of 2.71/10. Key technical indicators highlight an RSI of 51.68 and a MACD of -0.01, with the trend anchored by the 50-Day SMA at 1.25. Traders should monitor key support at 1.15 and resistance at 1.29.
